Further research is necessary to determine the successful engraftment efficiency of PDX models derived from biopsy, because they showed a trend of being marginally less likely to engraft in our cohort (Table 2 ) but present an opportunity for an even more potent clinical impact because we could gain more information about patients before a resection to inform neoadjuvant treatment approaches.
← all excerpts
Cancer "Avatars": Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer.
1
—
—